Effect of replacing the standard intravenous drug solvent from normal saline to 5% glucose solution on the incidence of hypernatremia in a COVID ICU: A before-and-after study
- Conditions
- E87.0Hyperosmolality and hypernatraemia
- Registration Number
- DRKS00031877
- Lead Sponsor
- Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Nephrology and Medical Intensive Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 192
Inclusion Criteria
ICU admission
COVID-19 as the main diagnosis during ICU treatment
Exclusion Criteria
Study ICU not the first admitting ICU at the Charité - Universitätsmedizin Berlin.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma sodium level
- Secondary Outcome Measures
Name Time Method Incidence of hypernatremia